The existence of a second GRPR binding site (see Table S1) with considerably higher affinity has never been described before for PC3 human prostate cancer cells, despite some examples which have been reported in the literature for bombesin/GRP binding in human breast cancer cells and mouse colon cancer cells [40,41]. Here, GRP is linked to prostate carcinoma.